US4023A
(en)
*
|
|
1845-05-01 |
|
Hijbst |
PT72878B
(en)
|
1980-04-24 |
1983-03-29 |
Merck & Co Inc |
Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
TW544448B
(en)
|
1997-07-11 |
2003-08-01 |
Novartis Ag |
Pyridine derivatives
|
GB9802251D0
(en)
|
1998-02-03 |
1998-04-01 |
Ciba Geigy Ag |
Organic compounds
|
KR20010088832A
(ko)
|
1998-10-02 |
2001-09-28 |
한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 |
통증 및 불안증 치료용 mGluR5 길항제
|
US6525203B1
(en)
|
1999-03-12 |
2003-02-25 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
CA2379421A1
(en)
*
|
1999-08-27 |
2001-03-08 |
Abbott Laboratories |
Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
|
GB0028702D0
(en)
|
2000-11-24 |
2001-01-10 |
Novartis Ag |
Organic compounds
|
CA2434558A1
(en)
|
2001-01-26 |
2002-08-01 |
Dmitry Zuev |
Imidazolyl derivatives as corticotropin releasing factor inhibitors
|
IL157815A0
(en)
|
2001-03-26 |
2004-03-28 |
Novartis Ag |
Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
|
CN103638514A
(zh)
|
2001-03-29 |
2014-03-19 |
药物协和公司 |
用于治疗组织炎症和癌变的鸟苷酸环化酶受体激动剂
|
JP3894035B2
(ja)
|
2001-07-04 |
2007-03-14 |
東レ株式会社 |
炭素繊維強化基材、それからなるプリフォームおよび複合材料
|
TW200306839A
(en)
|
2002-02-06 |
2003-12-01 |
Novartis Ag |
Quinazolinone derivatives and their use as CB agonists
|
US6696468B2
(en)
|
2002-05-16 |
2004-02-24 |
Dainippon Pharmaceutical Co., Ltd. |
(s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
|
SE0201940D0
(sv)
|
2002-06-20 |
2002-06-20 |
Astrazeneca Ab |
New combination II
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
GB0223730D0
(en)
|
2002-10-11 |
2002-11-20 |
Novartis Ag |
Organic compounds
|
PE20040844A1
(es)
|
2002-11-26 |
2004-12-30 |
Novartis Ag |
Acidos fenilaceticos y derivados como inhibidores de la cox-2
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
GB0302876D0
(en)
|
2003-02-07 |
2003-03-12 |
Novartis Ag |
Organic compounds
|
CA2514733A1
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
JP2004277318A
(ja)
|
2003-03-14 |
2004-10-07 |
Dainippon Pharmaceut Co Ltd |
1−(1−置換カルボニル−4−ピペリジニルメチル)ピペリジン誘導体およびそれを含有する医薬組成物
|
JP2004277319A
(ja)
|
2003-03-14 |
2004-10-07 |
Dainippon Pharmaceut Co Ltd |
1−(4−ピペリジニルメチル)ピペリジニルアミド誘導体およびそれを含有する医薬組成物
|
PL1644021T3
(pl)
|
2003-06-13 |
2013-01-31 |
Ironwood Pharmaceuticals Inc |
Sposoby i kompozycje do leczenia zaburzeń żołądkowo-jelitowych
|
US7491695B2
(en)
|
2003-06-18 |
2009-02-17 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic modulators of the ghrelin receptor
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
EP1505064A1
(en)
|
2003-08-05 |
2005-02-09 |
Bayer HealthCare AG |
2-Aminopyrimidine derivatives
|
DE602004009200T2
(de)
|
2003-08-12 |
2008-07-10 |
F. Hoffmann-La Roche Ag |
Tetrahydrochinazolinderivate als cfr-antagonisten
|
JP2007501822A
(ja)
|
2003-08-12 |
2007-02-01 |
エフ.ホフマン−ラ ロシュ アーゲー |
コルチコトロピン放出性因子(crf)アンタゴニストとしてのスピロ置換テトラヒドロキナゾリン
|
EP1664010A1
(en)
|
2003-08-29 |
2006-06-07 |
Vernalis (R&D) Limited |
Sulfonamides antagonising n-type calcium channels
|
OA13248A
(en)
|
2003-09-03 |
2007-01-31 |
Pfizer |
Benzimidazolone coumpounds having 5-HT4 receptor agonistic activity.
|
AU2004274403A1
(en)
|
2003-09-03 |
2005-03-31 |
Aventis Pharmaceuticals Inc. |
5-aryl-Pyrazolo(4,3-d)pyrimidines, pyridines, and pyrazines and related compounds
|
JP2005082508A
(ja)
|
2003-09-05 |
2005-03-31 |
Dainippon Pharmaceut Co Ltd |
2−アルコキシ−6−アミノ−5−ハロゲノ−n−(1−置換−4−ピペリジニル)ピリジン−3−カルボキサミド誘導体およびそれを含有する医薬組成物
|
AP2006003559A0
(en)
|
2003-09-05 |
2006-04-30 |
Neurogen Corp Ventis Pharmaceuticals Inc |
Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF 1 receptor ligands
|
US20070027156A1
(en)
|
2003-09-09 |
2007-02-01 |
Hisao Nakai |
Crf antagonists and heterobicyclic compounds
|
GB0322612D0
(en)
|
2003-09-26 |
2003-10-29 |
Novartis Ag |
Organic compounds
|
EP1670774A1
(en)
|
2003-09-30 |
2006-06-21 |
Janssen Pharmaceutica N.V. |
Quinoxaline compounds
|
JP2005104896A
(ja)
|
2003-09-30 |
2005-04-21 |
Dainippon Pharmaceut Co Ltd |
2−アルコキシ−6−アミノ−5−ハロゲノピリジン−3−カルボキサミド誘導体およびそれを含有する医薬組成物
|
BRPI0414918A
(pt)
|
2003-09-30 |
2006-11-07 |
Janssen Pharmaceutica Nv |
compostos de benzoimidazola
|
WO2005044793A2
(en)
|
2003-10-31 |
2005-05-19 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing fused heterocyclic compounds
|
CN1870999A
(zh)
|
2003-10-31 |
2006-11-29 |
阿斯利康(瑞典)有限公司 |
炔烃ⅰ
|
JP2007510741A
(ja)
|
2003-11-10 |
2007-04-26 |
メルク エンド カムパニー インコーポレーテッド |
ナトリウムチャンネル遮断薬としての置換トリアゾール類
|
US7208596B2
(en)
|
2003-11-25 |
2007-04-24 |
Bristol-Myers Squibb Pharma Company |
Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
|
WO2005054239A1
(en)
|
2003-12-05 |
2005-06-16 |
Bayer Healthcare Ag |
2-aminopyrimidine derivatives
|
US7211568B2
(en)
|
2003-12-18 |
2007-05-01 |
Kosan Biosciences Incorporated |
9-Desoxoerythromycin compounds as prokinetic agents
|
KR20060126993A
(ko)
|
2003-12-19 |
2006-12-11 |
아스트라제네카 아베 |
향대사성 글루탐산 수용체-5의 리간드로서의 5-플로오로,클로로- 및 시아노-피리딘-2-일-테트라졸
|
JP2005206590A
(ja)
|
2003-12-25 |
2005-08-04 |
Mitsubishi Pharma Corp |
ナトリウムチャネルサイト2選択的阻害剤
|
EP2194053B1
(en)
|
2004-01-07 |
2013-03-27 |
Armetheon, Inc. |
Methoxy piperidine derivatives for use inr the treatment of gastrointestinal and central nervous system disorders
|
TW200530181A
(en)
|
2004-01-13 |
2005-09-16 |
Bristol Myers Squibb Co |
Heterocyclic compounds useful as growth hormone secretagogues
|
DE602005005167T2
(de)
|
2004-01-29 |
2009-04-30 |
Pfizer Inc. |
1-isopropyl-2-oxo-1,2-dihydropyridin-3-carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
TW200533348A
(en)
|
2004-02-18 |
2005-10-16 |
Theravance Inc |
Indazole-carboxamide compounds as 5-ht4 receptor agonists
|
WO2005080356A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
|
PT1716152E
(pt)
|
2004-02-18 |
2008-10-02 |
Astrazeneca Ab |
Compostos heterocíclicos fundidos e sua utilização como antagonistas do receptor metabotrópico para o tratamento de distúrbios gastrointestinais
|
US7585881B2
(en)
|
2004-02-18 |
2009-09-08 |
Astrazeneca Ab |
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
UA82434C2
(uk)
|
2004-02-18 |
2008-04-10 |
Astrazeneca Ab |
Полігетероциклічні сполуки і їх застосування як антагоністів метаботропного рецептора глютамату, фармацевтична композиція на їх основі
|
BRPI0507499A
(pt)
|
2004-02-18 |
2007-07-24 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável ou hidrato dos mesmos, composição farmacêutica, uso do composto, e, métodos para tratar distúrbios mediados por mglur 5 e para inibir a ativação de receptores de mglur 5
|
EA200601266A1
(ru)
|
2004-02-18 |
2007-02-27 |
Астразенека Аб |
Соединения триазола и их применение в качестве антагонистов метаботропного рецептора глутамата
|
AU2005214380A1
(en)
|
2004-02-18 |
2005-09-01 |
Astrazeneca Ab |
Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
|
TW200538180A
(en)
|
2004-02-20 |
2005-12-01 |
Astrazeneca Ab |
New compounds
|
WO2005092882A1
(en)
|
2004-03-01 |
2005-10-06 |
Pfizer Japan, Inc. |
4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders
|
US7087749B2
(en)
|
2004-03-11 |
2006-08-08 |
Adolor Corporation |
Substituted piperidine compounds and methods of their use
|
AU2005226729B2
(en)
|
2004-03-25 |
2010-01-28 |
Janssen Pharmaceutica N.V. |
Imidazole compounds
|
AU2005231332A1
(en)
|
2004-03-29 |
2005-10-20 |
Merck & Co., Inc. |
Biaryl substituted pyrazinones as sodium channel blockers
|
US20050261332A1
(en)
|
2004-04-02 |
2005-11-24 |
Distefano Peter |
Sulfonamides and uses thereof
|
TWI351282B
(en)
|
2004-04-07 |
2011-11-01 |
Theravance Inc |
Quinolinone-carboxamide compounds as 5-ht4 recepto
|
EP1734820A4
(en)
|
2004-04-16 |
2008-01-23 |
Neurogen Corp |
Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
|
GB0412768D0
(en)
|
2004-06-08 |
2004-07-07 |
Novartis Ag |
Organic compounds
|
GB0412769D0
(en)
|
2004-06-08 |
2004-07-07 |
Novartis Ag |
Organic compounds
|
EA200801608A1
(ru)
|
2004-06-15 |
2008-10-30 |
Пфайзер Инк. |
Производные бензимидазолонкарбоновой кислоты
|
PE20060526A1
(es)
|
2004-06-15 |
2006-07-13 |
Schering Corp |
Compuestos triciclicos como antagonistas de mglur1
|
SE0401653D0
(sv)
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
New compounds
|
US20060035939A1
(en)
|
2004-07-14 |
2006-02-16 |
Japan Tobacco Inc. |
3-Aminobenzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity
|
JP4018739B2
(ja)
|
2004-07-15 |
2007-12-05 |
日本たばこ産業株式会社 |
縮合ベンズアミド化合物及びバニロイド受容体1型(vr1)活性阻害剤
|
US20080039430A1
(en)
|
2004-07-19 |
2008-02-14 |
Ali Ouaissi |
Pharmaceutical Compositions For The Treatment Of Leishmaniasis
|
RU2007107349A
(ru)
|
2004-07-28 |
2008-09-10 |
Глэксо Груп Лимитед (GB) |
Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств
|
ITMI20041566A1
(it)
|
2004-07-30 |
2004-10-30 |
Indena Spa |
"trpv1 agonisti, formulazioni che li contengono e loro usi"
|
WO2006016218A1
(en)
|
2004-08-03 |
2006-02-16 |
Pfizer Japan Inc. |
Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists
|
WO2006023757A2
(en)
|
2004-08-19 |
2006-03-02 |
University Of Virginia Patent Foundation |
Novel tricyclic, bicyclic, monocyclic, and acyclic amines as potent sodium channel blocking agents
|
AU2005284904A1
(en)
|
2004-09-13 |
2006-03-23 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
GB0420424D0
(en)
|
2004-09-14 |
2004-10-20 |
Ionix Pharmaceuticals Ltd |
Therapeutic compounds
|
US20060063792A1
(en)
|
2004-09-17 |
2006-03-23 |
Adolor Corporation |
Substituted morphinans and methods of their use
|
SE0402284D0
(sv)
|
2004-09-21 |
2004-09-21 |
Astrazeneca Ab |
New heterocyclic amides
|
WO2006036932A2
(en)
|
2004-09-27 |
2006-04-06 |
Elixir Pharmaceuticals, Inc. |
Sulfonamides and uses thereof
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
CN101223166B
(zh)
|
2004-10-07 |
2011-10-19 |
默沙东公司 |
噻唑基mglur5拮抗剂及其应用方法
|
EP1799661A1
(en)
|
2004-10-08 |
2007-06-27 |
AstraZeneca AB |
New hydroxymethylbenzothiazoles amides
|
US8143425B2
(en)
|
2004-10-12 |
2012-03-27 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
WO2006044527A1
(en)
|
2004-10-15 |
2006-04-27 |
Amgen Inc. |
Imidazole derivatives as vanilloid receptor ligands
|
ES2326827T3
(es)
|
2004-10-19 |
2009-10-20 |
Smithkline Beecham (Cork) Limited |
Anatagonistas del receptor de crf y metodos relacionados.
|
GB0519957D0
(en)
|
2005-09-30 |
2005-11-09 |
Sb Pharmco Inc |
Chemical compound
|
CA2584167A1
(en)
|
2004-10-22 |
2006-05-04 |
Amgen Inc. |
Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament
|
EP1809620B1
(en)
|
2004-11-04 |
2010-12-29 |
Addex Pharma SA |
Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
|
ATE431824T1
(de)
|
2004-11-05 |
2009-06-15 |
Theravance Inc |
Chinolinon-carboxamid-verbindungen
|
US7399862B2
(en)
|
2004-11-05 |
2008-07-15 |
Theravance, Inc. |
5-HT4 receptor agonist compounds
|
JP2008519794A
(ja)
|
2004-11-11 |
2008-06-12 |
アージェンタ・ディスカバリー・リミテッド |
ピリミジン化合物
|
US20060111416A1
(en)
|
2004-11-24 |
2006-05-25 |
Lane Charlotte A L |
Octahydropyrrolo[3,4-C]pyrrole derivatives
|
MX2007006205A
(es)
|
2004-11-24 |
2009-02-13 |
Abbott Lab |
Compuestos de cromanilurea que inhiben al receptor del receptor vanilloide subtipo 1 (vr1), y usos de los mismos.
|
WO2006058338A2
(en)
|
2004-11-29 |
2006-06-01 |
Janssen Pharmaceutica N.V. |
4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor
|
US7875627B2
(en)
|
2004-12-07 |
2011-01-25 |
Abbott Laboratories |
Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
|
US20060128710A1
(en)
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
US7615570B2
(en)
|
2004-12-13 |
2009-11-10 |
Abbott Laboratories |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
SE0403118D0
(sv)
|
2004-12-21 |
2004-12-21 |
Astrazeneca Ab |
New compounds 2
|
SE0403117D0
(sv)
|
2004-12-21 |
2004-12-21 |
Astrazeneca Ab |
New compounds 1
|
JP5159317B2
(ja)
|
2004-12-22 |
2013-03-06 |
セラヴァンス, インコーポレーテッド |
インダゾール−カルボキサミド化合物
|
SE0403171D0
(sv)
|
2004-12-23 |
2004-12-23 |
Astrazeneca Ab |
New compounds
|
EP1844044B1
(en)
|
2005-01-14 |
2010-07-21 |
F.Hoffmann-La Roche Ag |
Thiazole-4-carboxamide derivatives as mglur5 antagonists
|
US20080085901A1
(en)
|
2005-01-14 |
2008-04-10 |
Neurogen Corporation |
Heteroaryl Substituted Quinolin-4-Ylamine Analogues
|
US7429608B2
(en)
|
2005-01-20 |
2008-09-30 |
Amgen Inc. |
Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
|
US7301022B2
(en)
|
2005-02-15 |
2007-11-27 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
US20060183901A1
(en)
|
2005-02-17 |
2006-08-17 |
Theravance, Inc. |
Crystalline form of an indazole-carboxamide compound
|
GB0503646D0
(en)
|
2005-02-22 |
2005-03-30 |
Novartis Ag |
Organic compounds
|
DE602006014531D1
(de)
|
2005-03-03 |
2010-07-08 |
Janssen Pharmaceutica Nv |
Substituierte oxadiazaspiro-ä5.5ü-undecanonderivate und ihre verwendung als neurokininantagonisten
|
EP1858865B1
(en)
|
2005-03-10 |
2009-09-16 |
Pfizer Inc. |
Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
|
US20060211710A1
(en)
|
2005-03-17 |
2006-09-21 |
Pfizer Inc |
Substituted aryl 1,4-pyrazine derivatives
|
GB0506147D0
(en)
|
2005-03-24 |
2005-05-04 |
Merck Sharp & Dohme |
Therapeutic agents
|
WO2006102645A1
(en)
|
2005-03-24 |
2006-09-28 |
Janssen Pharmaceutica, N.V. |
Biaryl derived amide modulators of vanilloid vr1 receptor
|
US20060293309A1
(en)
|
2005-03-28 |
2006-12-28 |
Dynogen Pharmaceuticals, Inc. |
Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
|
TWI377206B
(en)
|
2005-04-06 |
2012-11-21 |
Theravance Inc |
Crystalline form of a quinolinone-carboxamide compound
|
WO2006113769A1
(en)
|
2005-04-15 |
2006-10-26 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
GB0508319D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
WO2006116563A1
(en)
|
2005-04-25 |
2006-11-02 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
GB0508318D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
GB0508314D0
(en)
|
2005-04-25 |
2005-06-01 |
Novartis Ag |
Organic compounds
|
GB0509573D0
(en)
|
2005-05-11 |
2005-06-15 |
Merck Sharp & Dohme |
Therapeutic compounds
|
MX2007014048A
(es)
|
2005-05-11 |
2008-02-05 |
Abbott Lab |
Antagonistas del receptor vaniloide subtipo 1 (vr1) y usos de los mismos.
|
JP2009536608A
(ja)
|
2005-05-11 |
2009-10-15 |
メルク シャープ エンド ドーム リミテッド |
バニロイド−1受容体(vr1)の機能を調節する2,3−置換縮合二環式ピリミジン4−(3h)−オン
|
MX2007013931A
(es)
|
2005-05-12 |
2008-01-11 |
Amgen Inc |
Agentes antipireticos contra incrementos en la temperatura corporal inducidos por antagonista del receptor vainilloide 1.
|
GB0510140D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B2
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
DE102005038947A1
(de)
|
2005-05-18 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
|
KR20080027463A
(ko)
|
2005-05-18 |
2008-03-27 |
아덱스 파마 에스에이 |
대사성 글루타메이트 수용체의 양성 알로스테릭조절자로서의 치환된 옥사디아졸 유도체
|
GB0510142D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds A1
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
DE102005023588A1
(de)
|
2005-05-18 |
2006-11-23 |
Grünenthal GmbH |
Salze substituierter Allophansäureester und deren Verwendung in Arzneimitteln
|
DE102005023784A1
(de)
|
2005-05-19 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
DE102005044813A1
(de)
|
2005-05-19 |
2007-10-04 |
Grünenthal GmbH |
Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
DE102005044814A1
(de)
|
2005-05-19 |
2006-11-23 |
Grünenthal GmbH |
Substituierte Sprio-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
|
DE102005024012A1
(de)
|
2005-05-20 |
2006-11-23 |
Grünenthal GmbH |
Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
|
US7582611B2
(en)
|
2005-05-24 |
2009-09-01 |
Pfizer Inc. |
Motilide compounds
|
MY147756A
(en)
|
2005-05-25 |
2013-01-15 |
Theravance Inc |
Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
|
JP5086248B2
(ja)
|
2005-06-07 |
2012-11-28 |
セラヴァンス, インコーポレーテッド |
5−ht4受容体アゴニストとしてのベンゾイミダゾロン−カルボキサミド化合物
|
US20060293370A1
(en)
|
2005-06-10 |
2006-12-28 |
Saunders Jeffrey O |
Sulfonamide compounds and uses thereof
|
CN101203511A
(zh)
|
2005-06-23 |
2008-06-18 |
阿斯利康(瑞典)有限公司 |
作为神经激肽受体拮抗剂用于治疗胃肠疾病的新氮杂环丁烷衍生物
|
JP2008546768A
(ja)
|
2005-06-23 |
2008-12-25 |
アストラゼネカ・アクチエボラーグ |
胃腸疾患を治療するためのニューロキニン受容体アンタゴニストとしての新規なアゼチジン誘導体
|
WO2007004041A2
(en)
|
2005-07-05 |
2007-01-11 |
Orchid Research Laboratories Limited |
New compounds and their pharmaceutical use
|
CA2612893A1
(en)
|
2005-07-05 |
2007-01-11 |
Aryx Therapeutics, Inc. |
Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders
|
US20080312209A1
(en)
|
2005-07-12 |
2008-12-18 |
Glaxo Group Limited |
Piperazine Heteroaryl Derivatives as Gpr38 Agonists
|
ES2333545T3
(es)
|
2005-07-22 |
2010-02-23 |
Pfizer, Inc. |
Derivados de indazolcarboxamida como agonistas de receptores 5ht4.
|
ES2410132T3
(es)
|
2005-07-22 |
2013-07-01 |
Ipsen Pharma |
Secretagogos de la hormona del crecimiento.
|
PE20070180A1
(es)
|
2005-07-26 |
2007-04-25 |
Glaxo Group Ltd |
Compuestos de bencilpiperazina como agonistas del receptor gpr38
|
EP1757290A1
(en)
|
2005-08-16 |
2007-02-28 |
Zentaris GmbH |
Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
|
US20090253634A1
(en)
|
2005-08-19 |
2009-10-08 |
Microbia, Inc. |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
|
WO2007023242A1
(en)
|
2005-08-24 |
2007-03-01 |
Merz Pharma Gmbh & Co. Kgaa |
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
|
EP1943247A1
(en)
|
2005-08-25 |
2008-07-16 |
Merz Pharma GmbH & Co.KGaA |
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
|
EP1940785A2
(en)
|
2005-09-08 |
2008-07-09 |
SmithKline Beecham Corporation |
Acyclic 1,4-diamines and uses thereof
|
EP1928862A1
(en)
|
2005-09-13 |
2008-06-11 |
Palau Pharma, S.A. |
2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity
|
AR056087A1
(es)
|
2005-09-29 |
2007-09-19 |
Astrazeneca Ab |
Derivados de azetidina como antagonistas de receptores de neuroquina nk
|
AR057828A1
(es)
|
2005-09-29 |
2007-12-19 |
Astrazeneca Ab |
Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
|
AR058807A1
(es)
|
2005-09-29 |
2008-02-27 |
Astrazeneca Ab |
5-(fenilisoxazoletoxi)-triazol-3-il piridinas sustituidas, para el tratamiento de trastornos mediados por el receptor mglur5
|
HUP0500920A2
(en)
|
2005-10-05 |
2007-07-30 |
Richter Gedeon Nyrt |
Oxadiazole derivatives, process for their preparation and their use
|
HUP0500921A2
(en)
|
2005-10-05 |
2007-07-30 |
Richter Gedeon Nyrt |
Tetrazole derivatives, process for their preparation and their use
|
EA200801013A1
(ru)
|
2005-10-07 |
2008-10-30 |
Гленмарк Фармасеутикалс С.А. |
Производные замещённых соединений, содержащих конденсированные бензольные кольца, и их применение в качестве лигандов ванилоидных рецепторов
|
US7902251B2
(en)
|
2005-10-19 |
2011-03-08 |
Allergan, Inc. |
Method for treating pain
|
CA2625189A1
(en)
|
2005-10-19 |
2007-04-26 |
Gruenenthal Gmbh |
Novel vanilloid receptor ligands and their use for producing medicaments
|
US20070088073A1
(en)
|
2005-10-19 |
2007-04-19 |
Allergan, Inc. |
Method for treating pain
|
US7538110B2
(en)
|
2005-10-27 |
2009-05-26 |
Adolor Corporation |
Opioid antagonists
|
CN102516176A
(zh)
|
2005-10-28 |
2012-06-27 |
雅培制药有限公司 |
抑制trpv1受体的吲唑衍生物
|
TW200732327A
(en)
|
2005-10-28 |
2007-09-01 |
Glaxo Group Ltd |
Novel compound
|
JP2007122605A
(ja)
|
2005-10-31 |
2007-05-17 |
Fujitsu Ltd |
インピーダンス回路、電源装置
|
US20070105920A1
(en)
|
2005-11-08 |
2007-05-10 |
Akzo Nobel N.V. |
2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives
|
GB0525661D0
(en)
|
2005-12-16 |
2006-01-25 |
Glaxo Group Ltd |
Novel compounds
|
NL2000323C2
(nl)
|
2005-12-20 |
2007-11-20 |
Pfizer Ltd |
Pyrimidine-derivaten.
|
WO2007090853A1
(en)
|
2006-02-10 |
2007-08-16 |
Cellzome (Uk) Ltd. |
Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders
|
EP1829879A1
(en)
|
2006-02-10 |
2007-09-05 |
Cellzome (UK) Ltd. |
Amino pyrimidine compounds for the treatment of inflammatory disorders
|
WO2007090854A1
(en)
|
2006-02-10 |
2007-08-16 |
Cellzome (Uk) Ltd. |
Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders
|
GB0603550D0
(en)
|
2006-02-22 |
2006-04-05 |
Glaxo Group Ltd |
Novel compounds
|
US20090192083A1
(en)
|
2006-02-24 |
2009-07-30 |
Currie Mark G |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20090305993A1
(en)
|
2006-02-24 |
2009-12-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and composition for the treatment of gastrointestinal disorders
|
US8597562B2
(en)
|
2006-03-30 |
2013-12-03 |
GM Global Technology Operations LLC |
Composite products and methods of making the same
|
US7713978B2
(en)
|
2006-03-31 |
2010-05-11 |
Nigel Paul King |
Compounds
|
EP2004188B1
(en)
|
2006-03-31 |
2010-09-01 |
Janssen Pharmaceutica NV |
Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor
|
BRPI0710083A2
(pt)
|
2006-03-31 |
2011-08-02 |
Janssen Pharmaceutica Nv |
entidade quìmica benzoimidazol-2-il pirimidina e pirazina, composição farmacêutica e uso destas
|
WO2007117401A2
(en)
|
2006-04-07 |
2007-10-18 |
Janssen Pharmaceutica N.V. |
Indoles and benzoimidazoles as modulators of the histamine h4 receptor
|
EP2007716A1
(en)
|
2006-04-13 |
2008-12-31 |
Glaxo Group Limited |
Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists
|
BRPI0710133A2
(pt)
*
|
2006-04-13 |
2012-10-30 |
Aegera Therapeutics Inc |
uso de compostos de imidazo[2,1-b]-1,3,4-tiadiazol-2-sulfonamida para tratar dor neuropática
|
EA015820B1
(ru)
|
2006-06-28 |
2011-12-30 |
Глэксо Груп Лимитед |
Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38
|
US8088733B2
(en)
|
2006-07-06 |
2012-01-03 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
|
BRPI0807046A2
(pt)
|
2007-02-09 |
2015-05-26 |
Tranzyme Pharma Inc |
Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit.
|
TWI423801B
(zh)
|
2007-08-27 |
2014-01-21 |
Theravance Inc |
作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
|
DE602008005771D1
(de)
|
2007-08-27 |
2011-05-05 |
Theravance Inc |
Disubstituierte alkyl-8-azabicycloä3.2.1üoktan-verbindungen als mu-opioid-rezeptorantagonisten
|
WO2009029253A1
(en)
|
2007-08-27 |
2009-03-05 |
Theravance, Inc. |
Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
|
US7902221B2
(en)
|
2007-08-27 |
2011-03-08 |
Theravance, Inc. |
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
|
WO2009144632A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Pfizer Limited |
Novel compounds
|
US7994203B2
(en)
*
|
2008-08-06 |
2011-08-09 |
Novartis Ag |
Organic compounds
|
WO2011043387A1
(ja)
*
|
2009-10-08 |
2011-04-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ピラゾロオキサゾール化合物
|